August 11, 2020 -- Samsung Biologics announced that it plans to break ground on a fourth plant in South Korea this year as part of a strategy to scale up development and manufacturing capabilities, in part due to COVID-19.
In total the company plans to invest over $2 billion in the two facilities, which will add 256-kiloliter capacity and begin manufacturing activities in the second half of 2022. The site will be the world's largest manufacturing facility at a single location. The plant will incorporate multiscale manufacturing by incorporating advantages from Samsung's three previous sites.
The 23.8 million sq m facility will incorporate real-time production schedule simulation with automation and the latest biomanufacturing technologies and utility supply-based optimization. The new site will contain streamlined application, smart disposal of high-concentration wastewater, and improvement of nitric acid emissions.
The company is also in negotiations with the authorities at the Incheon Free Economic Zone to purchase additional land for a second complex. This site is located near the company's current complex and will add 330,000 sq m of manufacturing space.
Copyright © 2020 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
